Stock Under $10 with 50-100% upside potential - 14 Days FREE!

8 Stocks Under $10 Moving Higher

Stock quotes in this article: HNSN, MOBI, KGN, DVAX, ONCY, MEA, REE, PCX 

Dynavax Technologies

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Dynavax Technologies (DVAX) is a biopharmaceutical company that discovers and develops products to prevent and treat infectious diseases, asthma and inflammatory and autoimmune diseases. This stock is trading up 10% at $4.05 in recent trading.

Today's Range: $3.65-$4.21

52-Week Range: $1.75-$3.83

Volume: 7.5 million

Three-Month Average Volume: 1.6 million

Shares of DVAX are soaring today after the company announced that it met with the FDA in a pre-BLA meeting, and Dynavax and the FDA have agreed that in the initial HEPLISAV BLA submission will be for an indication in healthy adults aged 18 to 70. This agreement represents a significant expansion of the previously anticipated population of healthy adults aged 40 and over.

From a technical standpoint, DVAX is starting to trigger a major breakout trade today with the stock moving above some near-term overhead resistance at $3.83 on monster volume. This move has now pushed DVAX into territory not seen since early 2008. The next significant overhead resistance level on DVAX sits at around $6, so as long as this breakout holds, traders should look for $6 to get it soon.

Dynavax shows up on a recent list of 10 Stocks of Top-Performing Funds in 2012 and was one of 13 Biotech Stocks Bought and Sold by Hedge Funds.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%
US 10 Yr 1.949% +0.084

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs